Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

NCT02547441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

463

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea

Interventions

DRUG: CLS001 (Omiganan)
DRUG: Vehicle

Sponsor

Maruho Co., Ltd.